IDEXX Laboratories, Inc. (BMV:IDXX)

Market Cap	972.57B
Revenue (ttm)	76.44B
Net Income (ttm)	18.85B
Shares Out	n/a
EPS (ttm)	231.12
PE Ratio	51.61
Forward PE	48.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49
Average Volume	62
Open	12,299
Previous Close	n/a
Day's Range	12,299 - 12,352
52-Week Range	7,650 - 14,130
Beta	n/a
RSI	53.66
Earnings Date	Feb 2, 2026

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1983
• Employees: 11,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: IDXX

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD